NFKB1 and glioblastoma: Ultimately, this work identified a novel susceptibility of glioblastoma cells to TNFR1-dependent apoptosis, dependent on inhibition of canonical NFκB signalling using our previously reported palbociclib-HMCD conjugate, 1 [23].